Stay updated on AT1001 Long-term Safety Study in Fabry Disease Clinical Trial
Sign up to get notified when there's something new on the AT1001 Long-term Safety Study in Fabry Disease Clinical Trial page.

Latest updates to the AT1001 Long-term Safety Study in Fabry Disease Clinical Trial page
- Check6 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, signaling a minor maintenance update to the ClinicalTrials.gov entry. This update does not reflect changes in the study data.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page content has been replaced with a generic error page (500) and the detailed Migalastat Fabry disease study information has been removed.SummaryDifference16%

- Check41 days agoChange DetectedThe page's revision indicator was updated from v3.6.3 to v3.6.4, reflecting a minor update to the page's version metadata.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page's revision label now reads v3.6.3, replacing the previous v3.6.2. This indicates a minor update to the page's release/version information.SummaryDifference0.1%

- Check70 days agoChange DetectedThe revision label on the page was updated from v3.6.0 to v3.6.2, indicating a minor update to the page's content or backend without changing study details.SummaryDifference0.1%

- Check84 days agoChange DetectedNo longer looking for participants is added, indicating recruitment has ceased for this study. New help sections How to Read a Study Record, Common Questions, and How to Join a Study were added, and minor UI label changes (Intervention/Treatment) alongside a revision update from v3.5.5 to v3.6.0 were implemented to reflect interface updates.SummaryDifference0.6%

Stay in the know with updates to AT1001 Long-term Safety Study in Fabry Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AT1001 Long-term Safety Study in Fabry Disease Clinical Trial page.